Fujifilm Philippines, a leader in imaging and healthcare technology, has expressed its support for the Department of Health (DOH) and the United States Agency for International Development (USAID) in their campaign to end tuberculosis (TB) in the country. According to 2022 data from the DOH, approximately 106 Filipinos die every day from TB, a severe lung infection caused by bacteria.
Fujifilm Philippines is dedicated to the fight against TB by introducing cutting-edge technologies and innovations. A significant contribution Fujifilm has made is providing the FDR Xair, a portable X-ray system. This innovative device plays a crucial role in early TB detection by enabling healthcare professionals to conduct rapid and accurate screenings in diverse settings. By deploying portable X-ray systems across the country, Fujifilm is helping bridge healthcare access gaps and improve diagnostic capabilities.
The FDR Xair is well known for its portability and high image quality, which plays a pivotal role in enhancing TB screening efforts, particularly in remote and underserved communities where access to healthcare infrastructure is limited. The device, with its portable design and advanced imaging technology, revolutionizes TB screening in remote areas by providing reliable performance, ease of use, and data-driven approaches to TB control.
Fujifilm’s innovative solutions align with the efforts of USAID’s TB Innovations and Health Systems Strengthening project, implemented by I-360, to reach, cure, and prevent TB in the country using a whole-of-government approach
Fujifilm Philippines conducted their first Medical Mission and TB screening using their X-ray systems (FDR Nano and FDR Go PLUS) in Mayapa, Laguna in 2023. The company plans to continue this program annually and utilize the FDR Xair. By working closely with affected communities, local healthcare providers, and grassroots organizations, the company ensures that TB interventions are culturally sensitive, equitable, and sustainable.
Recognizing the urgent need to enhance TB detection capabilities, Fujifilm Philippines is responding to the surge in cases across the country. As of December 31, 2023, the DOH recorded over 600,000 cases of TB, or 549 cases per 100,000 people. This figure is higher than that of 2022, with 438 cases per 100,000 people. Despite its lethality, TB can be cured through free medication provided at TB DOTS clinics nationwide, where patients undergo a six-month treatment regimen without interruption.
In light of the global challenge posed by TB, Fujifilm recognizes the necessity of a coordinated, multi-sectoral approach. The company stands in solidarity with governments, international organizations, civil society, and the private sector to tackle TB head-on with the shared goal of building a healthier, TB-free future.
This Press Release has also been published on VRITIMES
